Lazuna, Merlina .

HRN: 24-05-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 1.5GM (VIAL)
10/25/2024
10/26/2024
IV
1.5g
Ptor
Prophylaxis
Waiting Final Action 
10/26/2024
CEFUROXIME 500MG (TAB)
10/26/2024
11/01/2024
PO
500 Mg
BID
Sp Excision Of Bartholins Cyst
Waiting Final Action 
10/26/2024
CEFOTAXIME 500MG (VIAL)
10/26/2024
11/02/2024
ORAL
500mg
BID
S/P D&C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: